Navigation auf uzh.ch
Navigation auf uzh.ch
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression. Rabl, M., Zullo, L., Lewczuk, P. et al. Alz Res Therapy 16, 165 (2024). DOI: 10.1186/s13195-024-01526-4
Neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease: biomarker discovery using plasma proteomics, Rabl M, Clark C, Dayon L, et al, Journal of Neurology, Neurosurgery & Psychiatry (2024) DOI: 10.1136/jnnp-2024-333819
Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people – Effects of sex and APOEe4, Matteo Spinedi, Christopher Clark, Leonardo Zullo, Anja Kerksiek, Giorgio Pistis, Enrique Castelao, Armin von Gunten, Martin Preisig, Dieter Lütjohann, Julius Popp (2024). iScience, Volume 27, Issue 2, 2024 DOI: 10.1016/j.isci.2024.109013
Persisting neuropsychiatric symptoms, Alzheimer's disease and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate Ouanes, S, Rabl M, Clark C, Kirschbaum C, Popp J (2022).. Alz Res Therapy, 2022, 14, 19DOI: 10.1186/s13195-022-01139-9
Blood plasma protein profiles of neuropsychiatric symptoms and related cognitive decline in older people, Rabl M, Clark C, Dayon L, Bowman G, Popp J, J Neurochemistry 2022, 00, 1– 13 DOI: 10.1111/jnc.15715
Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people. Clark C, Richiardi, J, Maréchal B, Bowman G, Dayon L, Popp J. J Neuroinflammation 2022, 19, 127, DOI: 10.1186/s12974-022-02473-3
Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease, Mroczek M, Clark C, Dayon L, Bowman G, Popp J; DOI: 10.3390/cells11061030
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. Alzheimers Res Ther. 2021 Apr 1;13(1):71. DOI: 10.1186/s13195-021-00814-7
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression. Clark C, Lewczuk P, Kornhuber J, Richiardi J, Maréchal B, Karikari TK, Blennow K, Zetterberg H, Popp J. Alzheimers Res Ther. 2021 Mar 25;13(1):65 DOI: 10.1186/s13195-021-00805-8
Factors associated with subjective cognitive decline in dementia-free older adults-A population-based study. Zullo L, Clark C, Gholam M, Castelao E, von Gunten A, Preisig M, Popp J. Int J Geriatr Psychiatry. 2021 Feb 8. DOI: 10.1002/gps.5509
